Progressives didn’t win a clean sweep, but they emerged with an impressive scorecard, carrying seats in battlegrounds like ...

Leerink Partners analyst Faisal Khurshid reiterated a Buy rating on Pliant Therapeutics (PLRX – Research Report) yesterday and set a price ...

Pliant Therapeutics, Inc. ( (PLRX) ) has released its Q3 earnings. Here is a breakdown of the information Pliant Therapeutics, Inc. presented ...

INTEGRIS-PSC featured in an oral late breaker presentation SOUTH SAN FRANCISCO, Calif., Nov. 18, 2024 (GLOBE NEWSWIRE) -- Pliant Therapeuti ...